Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 2931-2940 of 9365

Page
per page
  1. Voglibose
    B1870 Voglibose
    Summary: α-glucosidases inhibitor
      insoluble in EtOH; ≥12.95 mg/mL
  2. VU 0361737
    B1630 VU 0361737
    Summary: MGlu4 receptor allosteric modulator
      Soluble in DMSO
  3. VU 0364770
    B1631 VU 0364770
    Summary: Positive allosteric modulator(PAM) of mGlu4
      Soluble in DMSO
  4. VUF 10166
    B2259 VUF 10166
    Target: 5-HT3 Receptors
    Summary: 5-HT3 receptor antagonist
      ≥26.3 mg/mL
  5. WAY-100635 maleate salt
    B2260 WAY-100635 maleate salt
    Summary: 5-HT1A receptor antagonist
      ≥53.9 mg/mL
  6. WAY-600
    B1641 WAY-600
    Target: mTOR
    Summary: MTOR inhibitor
      ≥12.38 mg/mL
  7. Xylometazoline HCl
    B2066 Xylometazoline HCl
    Summary: α1 and α2 adrenergic receptor agonist
      ≥14.04 mg/mL
  8. Zinc Pyrithione
    B2201 Zinc Pyrithione
    Target: Proton Pump
    Summary: Proton pump inhibitor
      insoluble in EtOH; insoluble in H2O; ≥13.45 mg/mL
  9. Sulbactam sodium
    B2035 Sulbactam sodium
    Summary: irreversible β-lactamase inhibitor
      insoluble in EtOH; ≥10.75 mg/mL
  10. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: Class III antiarrhythmic agent
      ≥25.6 mg/mL

Items 2931-2940 of 9365

Page
per page